LINFOMAS Y TRASPLANTES

Foto de LINFOMAS Y TRASPLANTES

Foto de University Hospital Heidelberg

University Hospital Heidelberg

Heidelberg, Alemania

Publicacións en colaboración con investigadores/as de University Hospital Heidelberg (5)

2024

Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: A prospective study
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 1

2021

Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491

2018

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
Leukemia, Vol. 32, Núm. 8, pp. 1799-1803

2016

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: An international, randomised, open-label, phase 3 study
The Lancet, Vol. 387, Núm. 10020, pp. 770-778

2015

Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
Bone Marrow Transplantation, Vol. 50, Núm. 6, pp. 802-807